Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026

Same author

A Major Step toward a Cure for Hepatitis B Infection.

The New England journal of medicine·2026

Same author

Hepatitis B: A Review.

JAMA·2026

Same author

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Hepatology communications·2026

Same author

A Self-Reported Electronic Body Map Identifies Distinct Clinical Pain Phenotypes in Chronic Pancreatitis.

Clinical and translational gastroenterology·2026

Same author

Animal Naming Test Predicts Future Overt Hepatic Encephalopathy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026

Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026

Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026

Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026

Same journal

What Is Low Back Pain?

JAMA·2026

Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026

查看所有相关文章

Search research articles

相关实验视频

Updated: Jul 11, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

乙型肝炎:一个审查

Francesco Negro¹, Anna S Lok²

¹Division of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland.

|November 9, 2023

概括

此摘要是机器生成的。

乙型肝炎病毒 (HDV) 感染,通常与乙型肝炎病毒 (HBV) 发生,加速肝病的进展. 在临床试验中, 像布莱维尔提德这样的新疗法对应这一重大全球健康问题具有前景.

科学领域:

肝病学和病毒学
传染性疾病
胃肠病学

更多相关视频

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

相关实验视频

Last Updated: Jul 11, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

背景情况:

肝炎D病毒 (HDV) 与肝炎B病毒 (HBV) 的同时感染影响全球数百万人,导致更严重的肝病,包括肝硬化和肝细胞癌.
慢性HBV携带者的HDV超级感染导致快速进展的肝病,肝硬化和死亡率高,尽管疾病的进展可能是可变的.

结论:

由于其侵袭性质和严重的肝脏并发症,高强度肝炎对全球健康构成重大负担.
虽然阿尔法干扰素提供了一些益处,但它的副作用很常见,针对HBV的治疗对HDV无效.
像布莱维这样的新兴治疗方法在治疗慢性HDV感染方面取得了重大进展,目前正在进行研究以优化治疗策略.